What are the adverse reactions of belinostat and what are the symptoms? =

Belinostat (Beleodaq), as a prescription drug for the treatment of peripheral T-cell lymphoma (PTCL), has brought new treatment hope to many patients, but it is also accompanied by a series of possible adverse reactions. These adverse reactions not only affect the patient's quality of life, but may also pose a serious threat to the patient's health.

Patients may experience a variety of adverse effects while receiving belinostat. Of these, low blood cell counts are a particular concern. A low platelet count may cause unusual bleeding or bruising under the skin, while a low red blood cell count may make the patient feel weak, tired, or even pale and short of breath. A low white blood cell count increases the risk of infection, which can sometimes be serious or even life-threatening.

In addition to low blood cell counts, serious infections are also one of the adverse reactions that need to be alerted to during treatment with belinostat. Patients may experience fever, flu-like symptoms, cough, shortness of breath and other signs of infection. The risk of this infection may be higher for patients who have received chemotherapy in the past. Therefore, patients should inform their doctor immediately if they develop any symptoms of infection.

Liver problems are also a possible serious adverse effect of belinostat. People may experience symptoms such as yellowing of the skin or the white parts of the eyes (jaundice), dark urine, and itching or pain in the right upper abdomen. These symptoms indicate that the liver may be damaged and require prompt medical treatment.

In addition, tumor lysis syndrome (TLS) is also a potential risk that needs attention during belinostat treatment. TLS is caused by the rapid decomposition of cancer cells and may lead to serious consequences such as electrolyte imbalance and kidney function damage. Therefore, doctors will closely monitor patients' TLS conditions during treatment.

In addition to the serious adverse reactions mentioned above, belinostat may also cause some more common but equally concerning symptoms, such as nausea, vomiting and diarrhea. These symptoms can sometimes be severe and interfere with the patient's daily life. Fortunately, doctors often prescribe medications to help prevent or treat these side effects.

In short, as an effective anti-cancer drug, belinostat may bring about a series of adverse reactions, but as long as it is used rationally under the guidance of a doctor, patients pay close attention to their symptoms and adjust the treatment plan in a timely manner, patients can still benefit from it. Patients should remain vigilant and communicate with their doctors promptly about any adverse reactions that may occur.

Reference: https://www.drugs.com/search.php?searchterm=BELEODAQ